These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin-2 for the treatment of melanoma. Tarhini AA; Agarwala SS Curr Opin Investig Drugs; 2005 Dec; 6(12):1234-9. PubMed ID: 16370388 [TBL] [Abstract][Full Text] [Related]
5. Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823 [TBL] [Abstract][Full Text] [Related]
6. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma. Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for metastatic melanoma: time for a change? Gogas HJ; Kirkwood JM; Sondak VK Cancer; 2007 Feb; 109(3):455-64. PubMed ID: 17200963 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094 [TBL] [Abstract][Full Text] [Related]
9. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for metastatic melanoma. MandarĂ M; Nortilli R; Sava T; Cetto GL Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649 [TBL] [Abstract][Full Text] [Related]
11. Treatment for metastatic malignant melanoma: old drugs and new strategies. Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957 [TBL] [Abstract][Full Text] [Related]
12. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma. Richtig E; Ludwig R; Kerl H; Smolle J Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601 [TBL] [Abstract][Full Text] [Related]
13. [DTIC in malignant melanoma: a perspective (author's transl)]. Kokoschka EM Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of neoadjuvant biochemotherapy for stage III melanoma. Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232 [TBL] [Abstract][Full Text] [Related]
15. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and targeted therapy combinations in advanced melanoma. Flaherty KT Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of advanced prostatic carcinoma. Millikan RE Semin Oncol; 1999 Apr; 26(2):185-91. PubMed ID: 10597729 [TBL] [Abstract][Full Text] [Related]
18. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250 [TBL] [Abstract][Full Text] [Related]
19. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? Eggermont AM; Kirkwood JM Eur J Cancer; 2004 Aug; 40(12):1825-36. PubMed ID: 15288283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]